The DOI matches its Crossref record; 54 of the 54 references it cites were found in a registry or an index.
Guillain-Barre syndrome and influenza vaccines: a meta-analysis.
Abstract
Cases of Guillain-Barré syndrome (GBS) have been occasionally associated with influenza vaccines; this possible risk, even if rare, is a matter of much concern. To investigate the strength of this association, a systematic review and a meta-analysis have been conducted; for the purpose, controlled observational studies addressing the risk of GBS associated with different influenza vaccines were sought. We finally selected 39 studies of interest published between 1981 and 2014 (seasonal influenza vaccines, 22; pandemic influenza vaccines, 16; both vaccines simultaneously administered, 1); funnel plot did not identify publication bias. At the association between any influenza vaccine - whether seasonal or pandemic - with GBS, the overall relative risk was 1.41 (95% CI, 1.20-1.66). Pandemic vaccines presented a higher risk (RR=1.84; 95% CI, 1.36-2.50) compared to seasonal vaccines (RR=1.22; 95% CI, 1.01-1.48); the latter should be considered as marginally statistically significant. Pandemic adjuvanted vaccines were not found to be related to a higher risk compared to non-adjuvanted vaccines. The results of the present meta-analysis point to a small but statistically significant association between influenza vaccines, particularly the pandemic ones, and GBS, which is consistent with current explanations upon possible mechanisms for this condition to appear.
Overview
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
In the citing paper
“A metanalysis of 39 controlled observational studies found that the relative risk of GBS following receipt of any influenza vaccine was 1.41 (Martin Arias et al., 2015).”
From Vaccine Safety: Myths and Misinformation (2020) · cites this paper as Martin Arias et al., 2015
Citations
Cites
Meta-analysis in clinical trials
DerSimonian, R., & Laird, N. (1986) · Controlled Clinical Trials · doi:10.1016/0197-2456(86)90046-2 · Cited by 39,552
Liberati, A., Altman, D. G., Tetzlaff, J., Mulrow, C., Gøtzsche, P. C., Ioannidis, J. P. A., Clarke, M., Devereaux, P. J., Kleijnen, J., & Moher, D. (2009) · PLoS Medicine · doi:10.1371/journal.pmed.1000100 · Cited by 28,164
Yuki, N., & Hartung, H. (2012) · New England Journal of Medicine · doi:10.1056/nejmra1114525 · Cited by 1,270
Population Incidence of Guillain-Barré Syndrome: A Systematic Review and Meta-Analysis
Sejvar, J. J., Baughman, A. L., Wise, M. P., & Morgan, O. W. (2011) · Neuroepidemiology · doi:10.1159/000324710 · Cited by 959
Schonberger, L. B., Bregman, D. J., SULLIVAN-BOLYAI, J. Z., Keenlyside, R. A., Ziegler, D. W., RETAILLIAU, H. F., EDDINS, D. L., & Bryan, J. A. (1979) · American Journal of Epidemiology · doi:10.1093/oxfordjournals.aje.a112795 · Cited by 784
Tutorial in biostatistics: the self‐controlled case series method
Whitaker, H. J., Paddy Farrington, C., Spiessens, B., & Musonda, P. (2006) · Statistics in Medicine · doi:10.1002/sim.2302 · Cited by 719
The Guillain–Barré Syndrome and the 1992–1993 and 1993–1994 Influenza Vaccines
Lasky, T., Terracciano, G. J., Magder, L. S., Koski, C. L., Ballesteros, M., Nash, D., Clark, S., Haber, P., Stolley, P. D., Schonberger, L. B., et al. (1998) · New England Journal of Medicine · doi:10.1056/nejm199812173392501 · Cited by 501
Vaccines and Guillain-Barré Syndrome
Haber, P., Sejvar, J. J., Mikaeloff, Y., & Destefano, F. R. (2009) · Drug Safety · doi:10.2165/00002018-200932040-00005 · Cited by 235
Salmon, D. A., Proschan, M. A., Forshee, R. A., Gargiullo, P. M., Bleser, W. K., Burwen, D. R., Cunningham, F. E., Garman, P. M., Greene, S. K., Lee, G. M., et al. (2013) · The Lancet · doi:10.1016/s0140-6736(12)62189-8 · Cited by 212
Guillain-Barré Syndrome After Influenza Vaccination in Adults
Juurlink, D. N. (2006) · Archives of Internal Medicine · doi:10.1001/archinte.166.20.2217 · Cited by 201
Cited by
Sorted by citations
Items 101–131 of 131
Doneddu, P. E., Briani, C., Cocito, D., Manganelli, F., Fabrizi, G. M., Matà, S., Mazzeo, A. T., Fazio, R., Benedetti, L., Luigetti, M., et al. (2023) · European Journal of Neurology · doi:10.1111/ene.15811 · Cited by 3
Identifying and reducing risks of neurological complications associated with vaccination
Handunnetthi, L., Ramasamy, M., Turtle, L. C. W., & Hunt, D. P. J. (2024) · Nature Reviews Neurology · doi:10.1038/s41582-024-01000-7 · Cited by 3
Lai, W.-C., Yang, C.-H., Huang, Y., Chiu, N.-C., & Chen, C. (2024) · Vaccines · doi:10.3390/vaccines12101133 · Cited by 2
Vaccination against COVID ‐19 does not lead to exacerbation in patients with myasthenia gravis
Breiner, A., & Bourque, P. R. (2022) · Muscle & Nerve · doi:10.1002/mus.27747 · Cited by 2
Liu, Z., Wang, J., Lu, Z., Xu, Y., Du, J., Han, J., Zhang, X., & Liu, Y. (2024) · Vaccines · doi:10.3390/vaccines12111298 · Cited by 1
Johnson, M., Windsor, R., Schmidt, J. L., Raczek, D. J., & Moore, G. E. (2025) · Journal of Veterinary Internal Medicine · doi:10.1111/jvim.70013 · Cited by 1
Fu, H.-M., Huang, Y., Wang, X., Zhang, Y., Liu, Y., Su, Y., & Pan, L. (2025) · Frontiers in Pediatrics · doi:10.3389/fped.2025.1640498 · Cited by 1
Damer, K. M., & Jung, C. M. (2016) · Side effects of drugs annual · doi:10.1016/bs.seda.2016.07.011 · Cited by 1
Treanor, J. J. (2023) · Springer eBooks · doi:10.1007/978-1-4939-9544-8_19-1 · Cited by 1
Destefano, F. R., Fisher, A., Shimabukuro, T. T., & Offit, P. A. (2023) · Elsevier eBooks · doi:10.1016/b978-0-323-79058-1.00083-9 · Cited by 1
Vaccination Strategies for a Liver Transplant Recipient
Sahu, M., Praharaj, D. L., & Bhadoria, A. S. (2024) · Journal of Clinical and Experimental Hepatology · doi:10.1016/j.jceh.2024.102421 · Cited by 1
Vacunas en personas adultas mayores sanas
Moral, E. G. (2024) · Actualización en Medicina de Familia · doi:10.55783/amf.200402 · Cited by 1
Shahri, M. S., Sadeghi, S., Fetratjoo, D. H., Hosseini, H., Ghobadi, M. A., Afshani, S. M., Mirhassani, R., Gohari, K., Havasi, F., Abdolghaffari, A., et al. (2024) · International Immunopharmacology · doi:10.1016/j.intimp.2024.112214 · Cited by 1
RetractedSuspect Guillain-Barré syndrome in a male rhesus macaque (Macaca mulatta)
Becker, T., Pieper, F., Liebetanz, D., Bleyer, M., Schrod, A., Mätz‐Rensing, K., & Treue, S. (2017) · Primate Biology · doi:10.5194/pb-4-27-2017
Do Vaccines Cause Guillain-Barré Syndrome (GBS)?
Dudley, M. Z., Salmon, D. A., Halsey, N. A., Orenstein, W. A., Limaye, R. J., O’Leary, S. T., & Omer, S. B. (2018) · Springer eBooks · doi:10.1007/978-3-319-94694-8_36
Vacunación del paciente tratado con fármacos inmunodepresores, inmunomoduladores o biológicos
Rodríguez-García, J. J., Fernández-Santos, R., & García‐Erce, J. A. (2018) · Medicina Clínica · doi:10.1016/j.medcli.2018.09.022
Polyradiculopathy in lyme disease: A case report
Knežević, S., Gajović, I., Đorđević, B., & Vulović, J. (2019) · Medicinski casopis · doi:10.5937/mckg53-23503
Guillain-Barre Syndrome: Review and Summary
Byers, M. S. (2021) · Journal of Biomedical Research & Environmental Sciences · doi:10.37871/jbres1297
Ling, L., Bagshaw, S. M., & Villeneuve, P.-M. (2022) · Canadian Medical Association Journal · doi:10.1503/cmaj.210947-f
A Case of Guillain-Barre Syndrome after COVID-19 Vaccination
Seok, J. I. (2021) · Korean Journal of Neuromuscular Disorders · doi:10.46518/kjnmd.2021.13.2.67
Vaccination of patients under immunosuppressive, immunomodulatory or biologic drugs
Rodríguez-García, J. J., Fernández-Santos, R., & García‐Erce, J. A. (2019) · Medicina Clínica (English Edition) · doi:10.1016/j.medcle.2018.09.016
Hong, B., Lee, H., Rhee, H., Kim, J. H., Jeon, H., Kim, S., Choi, N., Jung, S., & Shin, J. (2022) · Drug Targets and Therapeutics · doi:10.58502/dtt.22.004
Nörolojik Acil Durumlar ve Yönetimi
Ozsoy, A. C., DEMİR, H. A., Hür, İ., Çelik, A., Altınsoy, K. E., Bayhan, B. U., Karabay, O., Sayhan, M. B., Calp, B., Oğuz, S., et al. (2025) · Akademisyen Kitabevi eBooks · doi:10.37609/akya.3499
Williams, S. E., Anastasiou, O. E., Lino, M. M., Liang, C., Wu, J., Hall-Murray, C. K., Chilson, E. L., Dooling, K. L., Hayford, K., & Begier, E. M. (2026) · Human Vaccines & Immunotherapeutics · doi:10.1080/21645515.2026.2639750
Grapperon, A. (2026) · Encyclopédie médico-chirurgicale. Neurologie · doi:10.1016/s0246-0378(25)47132-2
Toriumi, S., Kurihara, Y., Shimokawa, K., Tanaka, A., Sugiura, Y., Araki, N., Kawai, O., & Uesawa, Y. (2026) · Pharmaceuticals · doi:10.3390/ph19050688
Pediatric Guillain–Barré Syndrome
Ginsberg, M. R. (2026) · Muscle & Nerve · doi:10.1002/mus.70268
Treanor, J. J. (2026) · Springer eBooks · doi:10.1007/978-1-4939-9544-8_19-3
Grapperon, A. (2026) · EMC - Neurologia · doi:10.1016/s1634-7072(26)51987-1
Su, Y., Huang, Y., Pan, L., Fu, H., & Wang, X. (2026) · Frontiers in Neurology · doi:10.3389/fneur.2026.1814946
Metadata
- Authors
- Martín Arias, L. H., Sanz, R., Sáinz, M., Treceño, C., & Carvajal, A.
- Affiliations
- Universidad de Valladolid (ES)
- Corresponding author
- Carvajal, A.
- ORCID
- Carvajal, A.
- Venue
- Vaccine
- Publisher
- Elsevier BV
- Published
- 2015-07
- Volume
- 33
- Issue
- 31
- Pages
- 3773-3778
- ISSN
- 0264-410X (ISSN-L)
- OpenAlex
- W324672716
- Cited by
- 132
- References
- 54
- Citations by year
- 2026: 7 · 2025: 12 · 2024: 11 · 2023: 11 · 2022: 15 · 2021: 28 · 2020: 13 · 2019: 11 · 2018: 10 · 2017: 8 · 2016: 6
- FWCI
- 1.05
- Type
- journal article
- Language
- en
- Open access
- closed
- Locations
- Vaccine (publishedVersion)
- PubMed (publishedVersion)
- Topics
- Health Sciences › Medicine › Clinical Neurology › Peripheral Neuropathies and Disorders
- Health Sciences › Medicine › Epidemiology › Influenza Virus Research Studies
- Life Sciences › Pharmacology, Toxicology and Pharmaceutics › Toxicology › Pharmacovigilance and Adverse Drug Reactions
- Keywords
- Guillain-Barré syndrome, influenza vaccination, vaccine adverse events, pandemic influenza vaccine, seasonal influenza vaccine, adjuvanted vaccine, relative risk, vaccine safety
- MeSH terms
- Influenza Vaccines, Guillain-Barre Syndrome, Observational Studies as Topic
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
